Status
Conditions
Treatments
About
This is an observational study of safety and occurrence of influenza-like illness following administration of flu cell culture derived adjuvanted swine origin A (H1N1) pandemic subunit vaccine in subjects 6 months of age and older.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
• Received any prior H1N1 vaccination
4,028 participants in 6 patient groups
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal